Related Experiment Videos

[Gene therapy and neurotrophic factor treatment for amyotrophic lateral sclerosis]

K Abe1, Y Manabe, T Murakami

  • 1Department of Neurology, Graduate School of Medicine and Dentistry, Okayama University.

Insights

Excitotoxicity and oxidative stress contribute to spinal neuron death. Glial cell line-derived neurotrophic factor (GDNF) gene therapy shows promise in protecting motor neurons in a mouse model of amyotrophic lateral sclerosis (ALS).

Area of Science:

  • Neuroscience
  • Cell Biology
  • Genetics

Context:

  • Excitotoxic and oxidative stress mechanisms in spinal neuron death are not fully understood.
  • Investigated cell damage in primary rat spinal cord cultures using glutamate, nitric oxide (NO), and peroxynitrite (PN).
  • Examined the protective effect of glial cell line-derived neurotrophic factor (GDNF) gene expression in transgenic mice with mutant SOD1, a model for familial amyotrophic lateral sclerosis (ALS).

Purpose:

  • To elucidate the roles of excitotoxicity and oxidative stress in spinal neuron apoptosis.
  • To evaluate the neuroprotective potential of GDNF gene therapy in a mouse model of ALS.

Summary:

  • Glutamate, NO, and PN induced apoptosis in rat spinal large motor neurons, confirmed by TUNEL assay.
  • GDNF gene therapy in G93A mutant SOD1 transgenic mice significantly increased large motoneuron survival compared to controls.
  • GDNF treatment preserved motoneurons, indicating its potential to delay ALS progression.

Impact:

  • Provides insights into the mechanisms of spinal neuron death.
  • Suggests GDNF gene therapy as a potential therapeutic strategy for ALS by promoting motoneuron survival.

Related Concept Videos